The state of the Life Sciences and Health Care industry
Finding the way forward
The growing affluence of Asia Pacific economies is translating into a greater demand for quality care and innovative medicines in the region. At the same time, the increasing digital disruption and shift from volume-based to value-based health care also mean that Life Sciences and Health Care companies will need to change the way they do business in the region.
Within the Life Sciences and Health Care industry, several overarching shifts include the move towards higher value-added economic activities, and the search for greater cost efficiency and productivity growth amidst challenges dealing with ageing populations and the greater onset of chronic diseases.
Succeeding in Asia Pacific requires Life Sciences and Health Care organisations to do more than implement one-size-fits-all strategies. Not only are localised strategies crucial in addressing the specific and idiosyncratic needs of each market, these strategies are also likely to be extremely varied across the diverse region.
This report takes a look at the Current state of the Life Sciences and Health Care industry in Asia Pacific, and explores its Future state, including several trends that could reshape the industry in the long term.